Product Program year 2025 Source: CMS Open Payments

General - Molecular Intervention

Device General - Molecular Intervention_IC

Open in the dashboard

General payments

$2,329

35 payments

Research payments

$0

0 payments

Through program year 2025, $2,329 in general payments and $0 in research payments were reported against General - Molecular Intervention (General - Molecular Intervention_IC).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2025 General $2,169 34
2022 General $160 1

Breakdown

Who paid General payments · program years 2022–2025
  1. Boston Scientific Corporation $2,329 35 payments
Top recipients General payments · program year 2025
  1. Divyesh Bhakta Interventional Cardiology · Louisville, KY $153 7% · 2 payments
  2. Armand Rothschild Cardiovascular Disease · Louisville, KY $148 7% · 1 payment
  3. Ibrahim Fahsah Interventional Cardiology · Louisville, KY $148 7% · 1 payment
  4. Vipul Panchal Cardiovascular Disease · Louisville, KY $148 7% · 1 payment
  5. Brian Jefferson Interventional Cardiology · Nashville, TN $148 7% · 1 payment

The top 5 of 24 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Interventional Cardiology Internal Medicine $1,125 52% · 13 practitioners
  2. Cardiovascular Disease Internal Medicine $962 44% · 9 practitioners
  3. Nurse Practitioner, Gerontology Nurse Practitioner $42 2% · 1 practitioner
  4. Nurse Practitioner, Psychiatric/Mental Health Nurse Practitioner $40 2% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2025
  1. Kentucky $1,698 78% · 20 recipients
  2. Indiana $148 7% · 1 recipient
  3. South Carolina $148 7% · 1 recipient
  4. Tennessee $148 7% · 1 recipient
  5. Maryland $26 1% · 1 recipient

Each share is of general payments naming this product in 2025 where a state was reported.

35 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record